Form 4: Iradimed Director James B. Hawkins Acquires Restricted Stock Units

Director James B. Hawkins of Iradimed Corporation received 1,811 restricted stock units under the company's 2023 Equity Incentive Plan.

Summary

• James B. Hawkins, a director at Iradimed Corporation, was granted 1,811 restricted stock units on December 11, 2024.
• These restricted stock units were awarded under the company's 2023 Equity Incentive Plan.
• The units will vest in two equal annual installments, starting on December 11, 2025.
• Upon vesting, each restricted stock unit will convert into one share of Iradimed common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock units to a director, which is a positive sign of alignment but not a major event.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units will vest in two equal annual installments beginning on December 11, 2025.

Industry Context

This is a standard practice for incentivizing directors and aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across the industry, including companies like Medtronic (MDT) and Boston Scientific (BSX), to align their interests with shareholders.
• The vesting schedule of two years is also typical, similar to what is seen in other medical device companies.
• The number of units granted is likely based on the director's role and the company's overall compensation strategy, which is consistent with industry norms.

Stakeholder Impact

• The grant of restricted stock units aligns the director's interests with those of the shareholders, potentially leading to better long-term performance.
• The vesting schedule encourages long-term commitment from the director.

Next Steps

• The restricted stock units will vest in two equal annual installments beginning on December 11, 2025.

Key Dates

Keywords

restricted stock units, equity incentive plan, director, insider trading, Iradimed, IRMD, stock options, vesting